4.5 Article

RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis

期刊

FRONTIERS IN BIOSCIENCE-LANDMARK
卷 17, 期 -, 页码 1120-1139

出版社

FRONTIERS IN BIOSCIENCE INC
DOI: 10.2741/3977

关键词

RUNX1; AML1; CBFA2; RUNX1-ETO; AML1-ETO; RUNX1-RUNX1T1; Hematopoiesis; Hematopoietic Stem Cells; Leukemia; AML; Leukemogenesis; Mouse Models; Review

资金

  1. National Institutes of Health [CA096735, CA10450, DK080665]
  2. NATIONAL CANCER INSTITUTE [R01CA096735] Funding Source: NIH RePORTER
  3. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL103106] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK080665] Funding Source: NIH RePORTER

向作者/读者索取更多资源

RUNX1 is a transcription factor that regulates critical processes in many aspects of hematopoiesis. RUNX1 is also integral in defining the definitive hematopoietic stem cell. In addition, many hematological diseases like myelodysplastic syndrome and myeloproliferative neoplasms have been associated with mutations in RUNX1. Located on chromosomal 21, the RUNX1 gene is involved in many forms of chromosomal translocations in leukemia. t(8,21) is one of the most common chromosomal translocations found in acute myeloid leukemia (AML), where it results in a fusion protein between RUNX1 and ETO. The RUNX1-ETO fusion protein is found in approximately 12% of all AML patients. In this review, we detail the structural features, functions, and models used to study both RUNX1 and RUNX1-ETO in hematopoiesis over the past two decades.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据